(PharmaNewsWire.Com, January 05, 2018 ) North America Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed. The North America Hormone Replacement Therapy Market is estimated at USD 6.77 billion in 2016 and is predicted to reach USD 9.55 billion by 2021, growing at a CAGR of 7.12%.
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of North America hormone replacement therapy market.
However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, high cost of therapy is limiting its reach to middle class people. Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of target audience.
Market Segmentation • By Hormone Type • By Route of Administration Morover, on the basis of geography, the North America hormone replacement therapy market is analysed under USA and Canada countries. USA dominates the market in the region owing to the economic conditions, awareness among women and government reimbursement policies present. Some of the key players operating in the North America hormone replacement industry are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer,Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
